Jin Medical International (ZJYL) Cash & Current Investments (2022 - 2025)

Jin Medical International (ZJYL) has disclosed Cash & Current Investments for 4 consecutive years, with $29.6 million as the latest value for Q3 2025.

  • Quarterly Cash & Current Investments rose 10.74% to $29.6 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $29.6 million through Sep 2025, up 10.74% year-over-year, with the annual reading at $29.6 million for FY2025, 10.74% up from the prior year.
  • Cash & Current Investments hit $29.6 million in Q3 2025 for Jin Medical International, up from $26.8 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $29.6 million in Q3 2025 to a low of $7.1 million in Q3 2022.
  • Historically, Cash & Current Investments has averaged $20.0 million across 4 years, with a median of $21.7 million in 2023.
  • Biggest five-year swings in Cash & Current Investments: skyrocketed 136.23% in 2023 and later increased 10.74% in 2025.
  • Year by year, Cash & Current Investments stood at $7.1 million in 2022, then skyrocketed by 136.23% to $16.7 million in 2023, then soared by 60.24% to $26.8 million in 2024, then grew by 10.74% to $29.6 million in 2025.
  • Business Quant data shows Cash & Current Investments for ZJYL at $29.6 million in Q3 2025, $26.8 million in Q3 2024, and $16.7 million in Q3 2023.